Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
73.26
+1.27 (1.76%)
At close: Oct 3, 2025, 4:00 PM EDT
72.39
-0.87 (-1.19%)
After-hours: Oct 3, 2025, 7:00 PM EDT
Doximity Revenue
Doximity had revenue of $145.91M in the quarter ending June 30, 2025, with 15.19% growth. This brings the company's revenue in the last twelve months to $589.64M, up 19.45% year-over-year. In the fiscal year ending March 31, 2025, Doximity had annual revenue of $570.40M with 19.98% growth.
Revenue (ttm)
$589.64M
Revenue Growth
+19.45%
P/S Ratio
23.29
Revenue / Employee
$710,405
Employees
830
Market Cap
13.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 570.40M | 94.98M | 19.98% |
| Mar 31, 2024 | 475.42M | 56.37M | 13.45% |
| Mar 31, 2023 | 419.05M | 75.50M | 21.98% |
| Mar 31, 2022 | 343.55M | 136.65M | 66.05% |
| Mar 31, 2021 | 206.90M | 90.51M | 77.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DOCS News
- 3 days ago - Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - Business Wire
- 2 months ago - Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Benzinga
- 2 months ago - Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers - CNBC
- 2 months ago - Doximity Acquires Pathway, a Leader in AI Clinical Reference - Business Wire
- 2 months ago - Doximity Announces Fiscal 2026 First Quarter Financial Results - Business Wire
- 2 months ago - New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures - Business Wire
- 2 months ago - Doximity: Slowing Sales And EBITDA Growth - Seeking Alpha